Cargando…

Effects of isomaltulose on insulin resistance and metabolites in patients with non-alcoholic fatty liver disease: A metabolomic analysis

Insulin resistance is associated with a poor prognosis in non-alcoholic fatty liver disease (NAFLD) patients. Isomaltulose, a naturally-occurring disaccharide, is reported to improve glucose and lipid metabolisms in obese patients. The present study aimed to investigate the effects of isomaltulose o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawaguchi, Takumi, Nakano, Dan, Oriishi, Tetsuharu, Torimura, Takuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072173/ https://www.ncbi.nlm.nih.gov/pubmed/29956790 http://dx.doi.org/10.3892/mmr.2018.9223

Ejemplares similares

Dipeptidyl Peptidase IV Inhibitor Improves Insulin Resistance and Steatosis in a Refractory Nonalcoholic Fatty Liver Disease Patient: A Case Report
por: Itou, Minoru, et al.
Publicado: (2012)

Association between Activity and Brain-Derived Neurotrophic Factor in Patients with Non-Alcoholic Fatty Liver Disease: A Data-Mining Analysis
por: Hashida, Ryuki, et al.
Publicado: (2021)

Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT)
por: Nakano, Dan, et al.
Publicado: (2020)

MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
por: Kawaguchi, Takumi, et al.
Publicado: (2022)

Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
por: Kawaguchi, Takumi, et al.
Publicado: (2022)

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
por: Takamura, Saori, et al.
Publicado: (2022)

Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease
por: Kumagai, Erina, et al.
Publicado: (2016)

Changes in prognostic factors for patients with hepatocellular carcinoma underwent transarterial chemoembolization with the transition of the time: Child-Pugh class, Albumin-Bilirubin grade, and then
por: Kawaguchi, Takumi, et al.
Publicado: (2020)

Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease
por: Shoji, Hirotaka, et al.
Publicado: (2016)

Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells
por: Nakano, Dan, et al.
Publicado: (2022)

Non‐alcoholic fatty liver disease in patients with autoimmune hepatitis
por: Takahashi, Atsushi, et al.
Publicado: (2018)

Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
por: Yki-Järvinen, Hannele
Publicado: (2015)

The Structural Basis of Erwinia rhapontici Isomaltulose Synthase
por: Xu, Zheng, et al.
Publicado: (2013)

Ethnic Variability in Glycemic Response to Sucrose and Isomaltulose
por: Tan, Wei Shuan Kimberly, et al.
Publicado: (2017)

Microbial metabolites in non-alcoholic fatty liver disease
por: Zhou, Da, et al.
Publicado: (2019)

The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients
por: Cetin, Elif Guven, et al.
Publicado: (2020)

Fatty liver biomarkers and insulin resistance indices in the prediction of non‐alcoholic fatty liver disease in Ghanaian patients
por: Bockarie, A. S., et al.
Publicado: (2023)

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
por: Du, Fan, et al.
Publicado: (2021)

Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
por: Park, Ji-Won, et al.
Publicado: (2021)

Spleen and Liver
por: Torimura, Takuji
Publicado: (2016)

Association of Osteoprotegerin with Obesity, Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Children
por: Erol, Meltem, et al.
Publicado: (2016)

Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees
por: Murayama, Kenichiro, et al.
Publicado: (2021)

Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
por: Yao, Jiayin, et al.
Publicado: (2013)

Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population
por: Zeng, Pei, et al.
Publicado: (2023)

Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial
por: Papandreou, Christopher, et al.
Publicado: (2017)

Low Glycemic Index Prototype Isomaltulose—Update of Clinical Trials
por: Maresch, Constanze Christin, et al.
Publicado: (2017)

Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
por: Zhou, Jin, et al.
Publicado: (2021)

Valine, a Branched-Chain Amino Acid, Reduced HCV Viral Load and Led to Eradication of HCV by Interferon Therapy in a Decompensated Cirrhotic Patient
por: Kawaguchi, Takumi, et al.
Publicado: (2012)

Editorial: The Metabolic (Dysfunction) Associated Fatty Liver Disease (MAFLD)-Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: A Forced Consensus and The Risk of a World Divide
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2022)

The Risk for Insulin Resistance according to the Degree of Non-Alcoholic Fatty Liver Disease in Korean Men
por: Ryoo, Jae-Hong, et al.
Publicado: (2016)

Association of calf circumference with insulin resistance and non-alcohol fatty liver disease: the REACTION study
por: Zhang, Weiwei, et al.
Publicado: (2017)

Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans
por: Apostolopoulou, Maria, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
por: Scapaticci, Serena, et al.
Publicado: (2021)

Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease
por: Shannon, Chris E., et al.
Publicado: (2020)

Neck Circumference as a Predictor of Insulin Resistance in People with Non-alcoholic Fatty Liver Disease
por: Son, Da-Hye, et al.
Publicado: (2023)

Short-term replacement of starch with isomaltulose enhances both insulin-dependent and -independent glucose uptake in rat skeletal muscle
por: Koshinaka, Keiichi, et al.
Publicado: (2018)

Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease
por: Gagnon, Eloi, et al.
Publicado: (2023)

Novel findings on the metabolic effects of the low glycaemic carbohydrate isomaltulose (Palatinose™)
por: Holub, Ines, et al.
Publicado: (2010)

The effects of isomaltulose ingestion on gastric parameters and cycling performance in young men
por: Miyashita, Masashi, et al.
Publicado: (2019)

Efficacy of Isomaltulose Compared to Sucrose in Modulating Endothelial Function in Overweight Adults
por: de Groot, Eric, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7stqnkoki0lsp2hh8bki5qp5i0